Neoadjuvant immunotherapy for resectable esophageal cancer: A protocol of meta-analysis

BACKGROUND: Esophageal cancer is a highly malignant cancer with a very poor prognosis. For resectable esophageal cancer, neoadjuvant treatment could improve the prognosis of esophageal cancer. However, current clinical neoadjuvant treatment options for esophageal cancer are still limited. The applic...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Guocan, Yu, Wenfeng, Xu, Xudong, Ye, Bo, Yao, Liwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Registered Report Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177427/
https://www.ncbi.nlm.nih.gov/pubmed/34086821
http://dx.doi.org/10.1371/journal.pone.0252829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177427/
https://www.ncbi.nlm.nih.gov/pubmed/34086821
http://dx.doi.org/10.1371/journal.pone.0252829

Ejemplares similares